Poster Session II - ACUTE ISCHEMIC STROKE MANAGEMENT 01.00 - ACUTE ISCHEMIC STROKE MANAGEMENT - 01.01 - ACUTE MANAGEMENT - Neither thrombolysis nor thrombectomy P654 - ESOC25-1345 THE METOCLOPRAMIDE FOR AVOIDING PNEUMONIA AFTER STROKE (MAPS-2): A SINGLE-BLIND RANDOMIZED CONTROLLED TRIAL OF METOCLOPRAMIDE FOR PREVENTION OF PNEUMONIA AFTER STROKE Anushka Warusevitane 1 , Craig Smith 2 , Anand Dixit 3 , Nikola Sprigg 4 , Reuben Ogollah 5 , Julius Sim 6 , Sue Jowett 7 , Diane Havard 4 , Lesia Kurlak 4 , Rebecca Ward 4 , Jared Palmer 4 , Iris Isheanesu Mhlanga 4 , Corinne Latulipe 4 , Lee Haywood 4 , Lisa Woodhouse 4 , Philip Bath 4 , Christine Roffe 1,6 1 Royal Stoke University Hospital, Stoke on Trent, United Kingdom, 2 Division of Cardiovascular Sciences, University of Manchester, Manchester, United Kingdom, 3 Freeman Hospital, Newcastle upon Tyne, United Kingdom, 4 Stroke Trials Unit, Mental Health and Clinical Neurosciences, University of Nottingham, Nottingham, United Kingdom, 5 Nottingham Clinical Trials Unit, University of Nottingham, Nottingham, United Kingdom, 6 School of Medicine, Keele University, Keele, United Kingdom, 7 Health Economics Unit, University of Birmingham, Birmingham, United Kingdom Background and Aims: Pneumonia causes more deaths than neurological damage after stroke
This means that even if I take it in an IV, my body may not have the enzyme available to make it into GSH
And if your recovery isnt what it used to be, or injuries keep coming back, youre not alone
How much solution do you need to draw
I.KelmanA
